Large-Scale in-House Cell-Based Assay for Evaluating the Serostatus in Patients with Neuromyelitis Optica Spectrum Disorder Based on New Diagnostic Criteria-Reference-Cited by-同舟云学术

Large-Scale in-House Cell-Based Assay for Evaluating the Serostatus in Patients with Neuromyelitis Optica Spectrum Disorder Based on New Diagnostic Criteria

Published:2017 Issue:2 Volume:13 Page:175
ISSN:1738-6586
Container-title:Journal of Clinical Neurology
language:en
Short-container-title:J Clin Neurol

Author:

Kim Yeseul¹²,Kim Gayoung¹²,Kong Byung Soo¹²,Lee Ji-Eun²³,Oh Yu-Mi²³,Hyun Jae-Won¹,Kim Su-Hyun¹,Joung AeRan¹,Kim Byoung Joon⁴,Choi Kyungho³,Kim Ho Jin¹²

Affiliation:

1. Department of Neurology, Research Institute and Hospital of National Cancer Center, Goyang, Korea.

2. Division of Translational and Clinical Research II, Research institute, National Cancer Center, Goyang, Korea.

3. Department of Biochemistry and Molecular Biology, and Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.

4. Department of Neurology, Sungkyunkwan University School of Medicine, Seoul, Korea.

Funder

Ministry of Science, ICT and Future Planning

Publisher

Korean Neurological Association

Subject

Neurology (clinical),Neurology

Link

https://synapse.koreamed.org/pdf/10.3988/jcn.2017.13.2.175

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update on aquaporin-4 antibody detection: the early diagnosis of neuromyelitis optica spectrum disorders;Multiple Sclerosis and Related Disorders;2024-10

2. Characteristics of recurrence in area postrema-onset NMO spectrum disorder - a retrospective cohort study;BMC Neurology;2024-05-21

3. Aquaporin-4-IgG positive neuromyelitis optica spectrum disorder in a paraneoplastic context;Journal of the Neurological Sciences;2023-11

4. Rapid Immunodot AQP4 Assay for Neuromyelitis Optica Spectrum Disorder;JAMA Neurology;2023-10-01

5. Aquaporin‐4 Antibody Dynamics and Relapse Risk in Seropositive Neuromyelitis Optica Spectrum Disorder Treated with Immunosuppressants;Annals of Neurology;2023-03-13